Close Menu

cytogenetics

Phalanx Biotech recently launched its CytoOneArray.

The Israeli government has decided to make microarray-based prenatal genetic testing available to its citizens for free.

By Justin Petrone
Taiwanese array vendor Phalanx Biotech will launch a microarray for cytogenetics research in the second quarter, entering a market already dominated by Agilent Technologies, Affymetrix, and others.

By Justin Petrone
Growing demand for arrays designed to detect tumor copy-number changes is enticing more chip manufacturers to offer tools tailor-made for cancer research.

The American College of Medical Genetics this month published recommendations for how best to design and interpret chromosomal microarrays used in clinical labs.

A company official shed little light on Agilent's plans for the diagnostics space, but an investment analyst said that the company will probably remain a peripheral player.

Pages

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.